The synergistic effect of activating all three receptors simultaneously promotes significant weight loss and better metabolic control than other existing GLP-1 receptor agonists, such as semaglutide (Wegovy and Ozempic), liraglutide, dulaglutide, and dual-agonists like tirzepatide (Mounjaro and Zepbound)
Men are more likely to cite cardiovascular risk reduction as a key driver
An integrated care approach involving meaningful collaborations between physicians and dietitians can promote sustainable behavior change by addressing behavioral and medical health needs
Eating frequent, smaller meals, as opposed to skipping or bingeing, makes the body use fuel more efficiently
You may opt out of marketing communications at any time by following the unsubscribe instructions in our emails or by contacting [email protected].
It may take several weeksor even monthsto see visible results, though the scale often reflects weight changes earlier